ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Votes To End Support For CCPDS July 31, 1983

May 14, 1982

Arizona First To Get Comprehensive Recognition Under New Guidelines; salmon Names Alberts As His Deputy, With Trent Going To Michigan

March 16, 1990

IOM Report Urges Providers To Address Psychological Needs Of Cancer Patients.

November 23, 2007

Upper Endoscopy Most Effective When Performed in 3-Year Intervals

July 27, 2012

ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community

May 8, 1981

In Brief: More Money For Fewer Grants? Or Spread It Around, Rhoads Asks; AACR To Take Stands

June 10, 1977